Pomalidomide is effective for prevention and treatment of experimental skin fibrosis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F12%3A%230002069" target="_blank" >RIV/00023728:_____/12:#0002069 - isvavai.cz</a>
Result on the web
<a href="http://ard.bmj.com/content/71/11/1895" target="_blank" >http://ard.bmj.com/content/71/11/1895</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1136/annrheumdis-2012-201784" target="_blank" >10.1136/annrheumdis-2012-201784</a>
Alternative languages
Result language
angličtina
Original language name
Pomalidomide is effective for prevention and treatment of experimental skin fibrosis
Original language description
We demonstrate for the first time that pomalidomide exerts potent antifibrotic effects in different preclinical models of skin fibrosis. These findings lend preclinical support for the linical studies of pomalidomide in SSc.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
ANNALS OF THE RHEUMATIC DISEASES
ISSN
0003-4967
e-ISSN
—
Volume of the periodical
71
Issue of the periodical within the volume
11
Country of publishing house
FI - FINLAND
Number of pages
5
Pages from-to
1895-1899
UT code for WoS article
000309654900023
EID of the result in the Scopus database
—